Gala Pharmaceutical Inc. (GLPH) SEC Filing 8-K Material Event for the period ending Thursday, January 10, 2019

Gala Pharmaceutical Inc.

CIK: 1513403 Ticker: GLPH

View differences made from one to another to evaluate Gala Pharmaceutical Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Gala Pharmaceutical Inc..


Assess how Gala Pharmaceutical Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Gala Pharmaceutical Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Gala Pharmaceutical Inc. provided additional information to their SEC Filing as exhibits

Ticker: GLPH
CIK: 1513403
Form Type: 8-K Corporate News
Accession Number: 0001683168-19-000091
Submitted to the SEC: Mon Jan 14 2019 3:51:21 PM EST
Accepted by the SEC: Mon Jan 14 2019
Period: Thursday, January 10, 2019
Industry: Apparel And Other Finishd Prods Of Fabrics And Similar Matl
  1. Accountant Change
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: